Brilique
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Brilique, covering 2026-03-31 to 2026-08-18. Get the full timeline:
Most recent: EMA Authorised: Brilique (ticagrelor) — AstraZeneca AB
2 regulatory and trial events tracked for Brilique, covering 2026-03-31 to 2026-08-18. Get the full timeline:
Most recent: EMA Authorised: Brilique (ticagrelor) — AstraZeneca AB